Current Molecular Pharmacology


Michael Kahn
(16435 citations)
Beckman Research Institute
City of Hope
Duarte, CA 91010-3000

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 1 Issue: 1, January

Organ- and Cell-Type Specific Delivery of Kinase Inhibitors: A Novel Approach in the Development of Targeted Drugs

Volume:1   Issue: 1
Pp: 1-12
Robbert J. Kok, Kai Temming and Marjan M. Fretz
DOI: 10.2174/1874467210801010001
Published on: 01 March, 2012

Gene Therapy: The First Approved Gene-Based Medicines, Molecular Mechanisms and Clinical Indications

Volume:1   Issue: 1
Pp: 13-23
J. K. Raty, J. T. Pikkarainen, T. Wirth and S. Yla-Herttuala
DOI: 10.2174/1874467210801010013
Published on: 01 March, 2012

Inhibitors of the Ubiquitin-Proteasome System and the Cell Death Machinery: How Many Pathways are Activated?

Volume:1   Issue: 1
Pp: 24-37
Claudio Brancolini
DOI: 10.2174/1874467210801010024
Published on: 01 March, 2012

Apoptosis-Regulatory Factors as Potential Drug Targets in the Epithelium of Normal and Inflamed Airways

Volume:1   Issue: 1
Pp: 38-49
P. D. Zalewski and R. E. Ruffin
DOI: 10.2174/1874467210801010038
Published on: 01 March, 2012

Pharmacology and Therapeutic Applications of Enediyne Antitumor Antibiotics

Volume:1   Issue: 1
Pp: 50-60
Rong-Guang Shao
DOI: 10.2174/1874467210801010050
Published on: 01 March, 2012

Pharmacologic Intervention in Axonal Excitability: In Vivo Assessment of Nodal Persistent Sodium Currents in Human Neuropathies

Volume:1   Issue: 1
Pp: 61-67
Satoshi Kuwabara and Sonoko Misawa
DOI: 10.2174/1874467210801010061
Published on: 01 March, 2012

Immunomodulatory Properties of Antibiotics

Volume:1   Issue: 1
Pp: 68-79
R. Nau and S. C. Tauber
DOI: 10.2174/1874467210801010068
Published on: 01 March, 2012

Targeting Cancer Cells by an Oxidant-Based Therapy

Volume:1   Issue: 1
Pp: 80-92
P. Buc Calderon, J. Verrax and H. Taper
DOI: 10.2174/1874467210801010080
Published on: 01 March, 2012